日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

First-in-class SAM-competitive G9a inhibitor FLAV-27 as a disease-modifying therapy for Alzheimer disease.

首个SAM竞争性G9a抑制剂FLAV-27作为阿尔茨海默病疾病修饰疗法。

Bellver-Sanchis Aina, Valle-Garcia David, Barbaraci Carla, Romero-Becerra Fernando, Singh Rohit Kumar, Jarne-Ferrer Júlia, Vasilopoulou Foteini, Irisarri Alba, Martínez-Fernández Carmen, Fafián-Labora Juan A, Arufe María C, Wüst Carolin, Castellanos Aida, Soto David, Casals Núria, Fadó Rut, Pocock Jennifer M, Navarro Gemma, Val Cristina, Brea José, Loza M Isabel, Lleó Albert, Fortea Juan, Alcolea Daniel, Perez-Bosque Anna, Miró Lluïsa, Pérez Belén, Rashid Sajid, Ali Muhammad, Saqib Manahil, Lí Carbó Marcel, Guerrero Ana, Vázquez Santiago, Choudhary Bhanwar Singh, Dai Shaodong, Escolano Carmen, Franco Rafael, Pallàs Mercè, Griñán-Ferré Christian

Beta-hydroxybutyrate counteracts the deleterious effects of a saturated high-fat diet on synaptic AMPAR receptors and cognitive performance.

β-羟基丁酸可抵消饱和高脂饮食对突触 AMPAR 受体和认知能力的有害影响

Rojas Rocío, Griñán-Ferré Christian, Castellanos Aida, Griego Ernesto, Martínez Marc, de Dios Navarro-López Juan, Jiménez-Díaz Lydia, Rodríguez-Álvarez José, Soto Del Cerro David, Castillo Pablo E, Pallàs Mercè, Casals Núria, Fadó Rut